January 2Jan 2 Chronic pain affects millions worldwide, pushing many to explore alternatives to conventional medications — including cannabis-based products. A large systematic review of randomized clinical trials has clarified how cannabis may (or may not) help people living with long-term pain. The analysis included data from more than 2,300 adults with persistent pain lasting months or years, focusing on how different products containing key cannabis compounds — THC (tetrahydrocannabinol) and CBD (cannabidiol) — influence pain levels and daily functioning.The review found that products with higher levels of THC — the psychoactive component of cannabis — were associated with small, short-term reductions in pain intensity and modest improvements in physical function, particularly for people with nerve-related (“neuropathic”) pain. These modest benefits suggest THC can provide some relief when other therapies fall short, but it’s not a dramatic or consistent analgesic for everyone. In contrast, products that were CBD-dominant or low in THC showed little to no meaningful pain relief in the reviewed studies, despite their widespread popularity and marketing as wellness or pain solutions. This indicates that CBD alone likely isn’t a strong option for chronic pain management based on current evidence.Across trials, side effects such as dizziness, sedation, and nausea were more common with higher-THC products. Because most studies were short-term and didn’t track long-term outcomes, questions remain about safety and sustained effectiveness. Researchers and clinicians emphasize that cannabis-based treatments are not a cure-all, and more high-quality, long-duration research is needed before cannabis can be embraced as a mainstay for chronic pain. Key TakeawaysTHC-rich cannabis products may offer modest short-term pain relief, especially for nerve pain, but gains are limited. CBD-only formulations show minimal benefit for chronic pain according to current evidence. Side effects and limited long-term data mean cannabis isn’t yet a widely recommended chronic pain therapyAdapted From:https://www.earth.com/news/does-cannabis-really-help-chronic-pain-a-large-review-offers-clarity/Link to study:https://www.acpjournals.org/doi/10.7326/ANNALS-25-03152Conclusion:Comparable and high THC-to-CBD ratio cannabinoid products may result in small improvements in pain and increased common adverse events during short-term treatment of primarily neuropathic pain; among high-ratio THC-only products, nabilone (but not dronabinol) reduced pain. Low THC-to-CBD products may not improve outcomes. Studies are needed on long-term outcomes and other cannabis product types.
January 2Jan 2 2 hours ago, Bacon1 said:THC-rich cannabis products may offer modest short-term pain relief, especially for nerve pain, but gains are limited.I was suffering bad pain from arthritis in my finger joints.0.5gm of hybrid (70% indica) cannabis smoked every night and it's totally gone, working well for 5 years now. The joint swelling all went as well.
Create an account or sign in to comment